Astex ranked in the top 20 of The Sunday Times ARM Tech Track 100
This year Astex has signed major deals with pharmaceutical companies Schering AG, to discover novel drugs to treat cancer, and AstraZeneca, to develop drug candidates for Alzheimer's disease. Astex also has drug discovery deals with Aventis, Mitsubishi Pharma Corporation and Fujisawa Pharmaceutical Co., Ltd. The company's annual sales growth in the period 2000-2002 was more than 170%.
"We are really pleased to appear in this prestigious listing of Britain's top technology companies. This achievement confirms the talent and commitment of Astex's team of professionals and is a tribute to everyone in the company," stated Mr. Timothy Haines, CEO of Astex.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.